ARCHIVES

Retrovirus Vaccination Is Feasible, Workshop Participants Conclude

This article is from The Cancer Letter archive.

Vol. 11 No. 18 | May 3, 1985

Download PDF Visit The Full Archive

Related Articles

Blackburn Wins BMS Award

May 23, 2003

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995

Conference Split Difference, NCI Gets $1.075 Billion

October 21, 1983

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009